Oral loading with propafenone for conversion of recent-onset atrial fibrillation: A review on in-hospital treatment

Drugs

Volumn 62, Issue 3, 2002, Pages 415-423

  Boriani, Giuseppe ^a   Martignani, Cristian ^a   Biffi, Mauro ^a   Capucci, Alessandro ^a   Branzi, Angelo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYPROPAFENONE; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DISOPYRAMIDE; DOFETILIDE; ESMOLOL; FLECAINIDE; IBUTILIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

BED REST; BRADYCARDIA; CARDIOVERSION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLASSIFICATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART PROARRHYTHMIA; HOSPITAL CARE; HUMAN; HYPOTENSION; INOTROPISM; LONG QT SYNDROME; OUTPATIENT CARE; PRACTICE GUIDELINE; REVIEW; TORSADE DES POINTES; TREATMENT OUTCOME;

EID: 0036186753     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200262030-00001     Document Type: Review

References (46)

1. Atrial fibrillation and stroke: New ideas, persisting dilemmas
2. Epidemiology of atrial fibrillation
3. Atrial arrhythmias
4. Atrial fibrillation: Maintenance of sinus rhythm versus rate control
5. Acute treatment of atrial fibrillation: Why and when to maintain sinus rhythm
6. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
7. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide
8. Minimal efficacious concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy
9. Propafenone for conversion of recent onset atrial fibrillation-a controlled comparison between oral loading dose and intravenous administration
10. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease
11. Conversion of recent-onset atrial fibrillation to sinus rhythm: Effects of different drug protocols
12. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm
13. Oral loading with propafenone: A placebo-controlled study in elderly and non-elderly patients with recent-onset atrial fibrillation
14. Acute treatment of atrial fibrillation
15. The multiple modes of action of propafenone
16. Subgroups of class 1 antiarrhythmic drugs
17. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias
18. Relationships between debrisoquine hydroxylation and propafenone pharmacokinetics
19. β-Blocking properties of propafenone in extensive oxidisers: A study on heart rate behaviour during Holter monitoring
20. Potassium channel blocking properties of propafenone in rat atrial myocytes
21. Propafenone: A review on its pharmacodynamic properties, and therapeutic use in the treatment of arrhythmias
22. Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset
23. Guidelines for the use of propafenone in treating supraventricular arrhythmias
24. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias
25. Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: A meta-analysis
26. Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: A placebo-controlled study
27. Proarrhythmia in patients treated for atrial fibrillation or flutter
28. Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation
29. Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: Is in-hospital admission absolutely necessary?
30. Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: Comparison of two regimens
31. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm
32. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus-rhythm: A prospective parallel placebo-controlled multicentre study
33. Comparison of oral loading dose of propafenone and amiodarone for converting recent onset atrial fibrillation
34. Home treatment of recent onset atrial fibrillation with a single oral loading dose of flecainide or propafenone: An efficacious, reproducible and safe procedure
35. Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm
36. Predictors of success in the conversion of new-onset atrial fibrillation using oral propafenone
37. Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room. A randomized trial
38. Intravenous amiodarone in treatment of recent-onset atrial fibrillation results of a randomized controlled study
39. The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation
40. Atrial flutter in patients treated for atrial fibrillation with propafenone
41. Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs
42. Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm
43. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle length and relation with arrhythmia termination
44. Compared effects of sotalol, flecainide and propafenone on ventricular repolarisation in patients free of underlying structural heart disease
45. Torsade de pointes ventricular tachycardia in a hypothyroid patient treated with propafenone
46. Propafenone-induced torsade de pointes: Cross-reactivity with quinidine